Equithrive Joint is a unique resveratrol-based formula that supports healthy joint function in your horse. Resveratrol reduces gene expression of inflammatory mediators to allow your horse to move comfortably during aging, training and competition. Equithrive Joint was released in 2009 and is the true pioneer product in equine resveratrol therapy. Researchers at the Gluck Equine Research Center have evaluated this product and verified that daily administration of Equithrive Joint produces a statistically significant reduction in circulating levels of inflammatory mediators.
Equithrive Joint contains our proprietary microencapsulated resveratrol product Resverasyn®. Microencapsulation ensures resveratrol is absorbed in the gastrointestinal tract and transported throughout the body to reduce the production of inflammatory mediators. When not microencapsulated, resveratrol is rapidly metabolized and excreted before the compound can reach tissues and exert its effects in your horse. Equithrive Joint also contains hyaluronic acid, the primary component of joint-lubricating synovial fluid and cartilage. Supplementation with hyaluronic acid may prevent the concentration of this compound from diminishing in synovial fluid and connective tissues during the natural aging process.
Equithrive Joint is a stand alone product that does not require co-administration of any other nutraceuticals or supplements to support soundness and continued joint health in your horse. Equithrive Joint is a powdered product that can be administered with a horse's daily feed ration.